VLife Sciences Technologies Overview
- Year Founded
-
2002

- Status
-
Acquired/Merged
- Employees
-
20

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
VLife Sciences Technologies General Information
Description
Provider of licensed software and research solutions for research projects in a variety of sectors including genotoxicity predictions. The company's software offers numerous unique and specialized features for applications in computer-aided molecular discovery, bioinformatics, biotechnology, and chemoinformatics.
Contact Information
Website
www.vlifesciences.com(Operating Subsidiary)
Corporate Office
- 2nd and 3rd Floor, Plot No-05, Next to Sapling Nursery
- Ram Indu Park, Survey No-131/1b/2/11, Baner Road
- Pune, Maharashtra 411045
- India
Corporate Office
- 2nd and 3rd Floor, Plot No-05, Next to Sapling Nursery
- Ram Indu Park, Survey No-131/1b/2/11, Baner Road
- Pune, Maharashtra 411045
- India
VLife Sciences Technologies Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
VLife Sciences Technologies Comparisons
Industry
Financing
Details
VLife Sciences Technologies Competitors (3)
One of VLife Sciences Technologies’s 3 competitors is Conifer Point Pharmaceuticals, a Corporate Backed or Acquired company based in Doylestown, PA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Conifer Point Pharmaceuticals | Corporate Backed or Acquired | Doylestown, PA | ||||
Pharmacelera | Venture Capital-Backed | Barcelona, Spain | ||||
Cyrus Biotechnology | Venture Capital-Backed | Seattle, WA |
VLife Sciences Technologies Patents
VLife Sciences Technologies Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
ES-2443159-T3 | Topical formulation for diabetic foot ulcers | Active | 22-Sep-2009 | ||
US-8741953-B2 | Topical formulation for diabetic foot ulcers | Active | 22-Sep-2009 | ||
CA-2775317-A1 | Topical formulation for diabetic foot ulcers | Active | 22-Sep-2009 | ||
US-20120196930-A1 | Topical formulation for diabetic foot ulcers | Active | 22-Sep-2009 | ||
CA-2775317-C | Topical formulation for diabetic foot ulcers | Active | 22-Sep-2009 | A61K31/24 |
VLife Sciences Technologies Signals
VLife Sciences Technologies FAQs
-
When was VLife Sciences Technologies founded?
VLife Sciences Technologies was founded in 2002.
-
Where is VLife Sciences Technologies headquartered?
VLife Sciences Technologies is headquartered in Pune, India.
-
What is the size of VLife Sciences Technologies?
VLife Sciences Technologies has 20 total employees.
-
What industry is VLife Sciences Technologies in?
VLife Sciences Technologies’s primary industry is Other Healthcare Technology Systems.
-
Is VLife Sciences Technologies a private or public company?
VLife Sciences Technologies is a Private company.
-
What is VLife Sciences Technologies’s current revenue?
The current revenue for VLife Sciences Technologies is
. -
How much funding has VLife Sciences Technologies raised over time?
VLife Sciences Technologies has raised $1.15M.
-
Who are VLife Sciences Technologies’s competitors?
Conifer Point Pharmaceuticals, Pharmacelera, and Cyrus Biotechnology are competitors of VLife Sciences Technologies.
-
When was VLife Sciences Technologies acquired?
VLife Sciences Technologies was acquired on 31-Oct-2013.
-
Who acquired VLife Sciences Technologies?
VLife Sciences Technologies was acquired by Novalead Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »